Firefly
2 known investors
Firefly Bio develops antibody-drug conjugates (ADCs) that use novel classes of payloads, drawing on a research team experienced in ADC discovery and development. The company operates in the oncology and immunology biotech space.
Founders & leadership
SH
Scott HirschCEO
DK
Dan KaplanCSO
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountIPOAug 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 2
by search overlapFirefly Aerospace11 shared keywordsFirefly Aerospace launches, lands, and operates space systems spanning Earth orbit to the Moon and cislunar space, serving customers such as commercial companies, NASA, and the U.S. Space Force. It develops the Alpha and Eclipse launch vehicles, Blue Ghost lunar landers, and Elytra orbital vehicles for payload delivery and in-space services.
Firefly Health10 shared keywordsFirefly Health provides virtual primary care through dedicated care teams that include primary care physicians, nurse practitioners, health guides, nurses, and behavioral health specialists. Care is delivered via video calls and chat through the Firefly Health app.
Companies competing with Firefly for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Muon Space raises $250M at $1.5B valuation to scale up satellite output - SiliconANGLEsiliconangle.com · Aug 2026
AI workload optimization startup Callosum raises $100M - SiliconANGLEsiliconangle.com · Aug 2026
Firefly Announces Record Q2 Resultspayloadspace.com · Aug 2026Frequently asked questions
- What does Firefly do?
- Firefly Bio develops antibody-drug conjugates (ADCs) that use novel classes of payloads, drawing on a research team experienced in ADC discovery and development. The company operates in the oncology and immunology biotech space.
- Who are Firefly's investors?
- Firefly's investors include Decheng Capital, MPM BioImpact.